An Anti-CD103 immunotoxin promotes long-term survival of pancreatic islet allografts

American Journal of Transplantation

Volumn 9, Issue 9, 2009, Pages 2012-2023

  Zhang, L ^a,b   Moffatt Bruce, S D ^a   Gaughan, A A ^a   Wang, J J ^a   Rajab, A ^a   Hadley, G A ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

CD8 T lymphocytes; Immunosuppression; Integrin; Pancreatic islet transplantation; Regulatory T cells; Thymus

Indexed keywords

CD103 ANTIGEN; IMMUNOMODULATING AGENT; IMMUNOTOXIN; M290 SAP; SAPORIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; FEMALE; IN VIVO STUDY; LONG TERM CARE; MOUSE; NONHUMAN; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SURVIVAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNOSUPPRESSION; INTEGRIN ALPHA CHAINS; INTEGRINS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LEUKOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; THYMUS GLAND; TRANSPLANTATION, HOMOLOGOUS;

EID: 69149089544     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02735.x     Document Type: Article

References (41)

1. Gjertson DW. Determinants of long-term survival of adult kidney transplants: A 1999 UNOS update. Clin Transpl 1999 341 352.
2. Cerf-Bensussan N, Jarry A, Brousse N et al. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol 1987 17 : 1279 1285.
3. Karecla PI, Bowden SJ, Green SJ, Kilshaw PJ. Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alpha M290 beta 7 (alpha E beta 7). Eur J Immunol 1995 25 : 852 856.
4. Cepek KL, Shaw SK, Parker CM et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 1994 372 : 190 193.
5. Hadley GA, Bartlett ST, Via CS, Rostapshova EA, Moainie S. The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL. J Immunol 1997 159 : 3748 3756.
6. Robertson H, Wong WK, Talbot D, Burt AD, Kirby JA. Tubulitis after renal transplantation: Demonstration of an association between CD103+ T cells, transforming growth factor beta1 expression and rejection grade. Transplantation 2001 71 : 306 313.
7. Dogan A, Wang ZD, Spencer J. E-cadherin expression in intestinal epithelium. J Clin Pathol 1995 48 : 143 146.
8. Cirulli V, Baetens D, Rutishauser U, Halban PA, Orci L, Rouiller DG. et al. Expression of neural cell adhesion molecule (N-CAM) in rat islets and its role in islet cell type segregation. J Cell Sci 1994 107 (Pt 6 1429 1436.
9. Nouwen EJ, Dauwe S, van der Biest I, De Broe ME. Stage- and segment-specific expression of cell-adhesion molecules N-CAM, A-CAM, and L-CAM in the kidney. Kidney Int 1993 44 : 147 158.
10. Katagiri, A, Watanabe R, Tomita Y. E-cadherin expression in renal cell cancer and its significance in metastasis and survival. Br J Cancer 1995 71 : 376 379.
11. Terada T, Ashida K, Kitamura Y. Expression of epithelial-cadherin, alpha-catenin and beta-catenin during human intrahepatic bile duct development: A possible role in bile duct morphogenesis. J Hepatol 1998 28 : 263 269.
12. Feng Y, Wang D, Yuan R, Parker CM, Farber DL, Hadley GA. CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells. J Exp Med 2002 196 : 877 886.
13. Yuan R, El-Asady R, Liu K, Wang D, Drachenberg CB, Hadley GA. Critical role for CD103+CD8+ effectors in promoting tubular injury following allogeneic renal transplantation. J Immunol 2005 175 : 2868 2879.
14. El-Asady R, Yuan R, Liu K et al. TGF-beta-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease. J Exp Med 2005 201 : 1647 1657.
15. Lefrancois L, Barrett TA, Havran WL, Puddington L. Developmental expression of the alpha IEL beta 7 integrin on T cell receptor gamma delta and T cell receptor alpha beta T cells. Eur J Immunol 1994 24 : 635 640.
16. Staton TL, Johnston B, Butcher EC, Campbell DJ. Murine CD8+ recent thymic emigrants are alphaE integrin-positive and CC chemokine ligand 25 responsive. J Immunol 2004 172 : 7282 7288.
17. Kilshaw PJ. Expression of the mucosal T cell integrin alpha M290 beta 7 by a major subpopulation of dendritic cells in mice. Eur J Immunol 1993 23 : 3365 3368.
18. Lehmann J, Huehn J, de la Rosa M et al. Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc Natl Acad Sci U S A 2002 99 : 13031 13036.
19. Smith TJ, Ducharme LA, Shaw SK et al. Murine M290 integrin expression modulated by mast cell activation. Immunity 1994 1 : 393 403.
20. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP. An improved method for isolation of mouse pancreatic islets. Transplantation 1985 40 : 437 438.
21. Guy-Grand, D, Griscelli C, Vassalli P. The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-versus-host conditions. J Exp Med 1978 148 : 1661 1677.
22. Gudmundsdottir H, Turka LA. A closer look at homeostatic proliferation of CD4+ T cells: Costimulatory requirements and role in memory formation. J Immunol 2001 167 : 3699 3707.
23. Stirpe F, Derenzini M, Barbieri L. Hepatotoxicity of immunotoxins made with saporin, a ribosome-inactivating protein from Saponaria officinalis. Virchows Arch B Cell Pathol Incl Mol Pathol 1987 53 : 259 271.
24. Schon MP, Arya A, Murphy EA et al. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol 1999 162 : 6641 6649.
25. Stirpe F, Barbieri L, Battelli MG, Soria M, Lappi DA. Ribosome-inactivating proteins from plants: Present status and future prospects. Biotechnology (N Y) 1992 10 : 405 412.
26. Bagga S, Seth D, Batra JK. The cytotoxic activity of ribosome- inactivating protein saporin-6 is attributed to its rRNA N-glycosidase and internucleosomal DNA fragmentation activities. J Biol Chem 2003 278 : 4813 4820.
27. Fry TJ, Mackall CL. The many faces of IL-7: From lymphopoiesis to peripheral T cell maintenance. J Immunol 2005 174 : 6571 6576.
28. Pearl JP, Parris J, Hale DA et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005 5 : 465 474.
29. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 252.
30. Lechler R, Ng WF, Steinman RM. Dendritic cells in transplantation-friend or foe? Immunity 2001 14 : 357 368.
31. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007 449 : 419 426.
32. Van Den Broek M. Dendritic cells break bonds to tolerize. Immunity 2007 27 : 544 546.
33. Galkowska H, Olszewski WL, Moscicka M et al. Skin allografts-lymph veiled (dendritic) cells are responsible for initiation of rejection in canine skin/SCID mouse chimera model. Ann Transplant 1999 4 : 5 10.
34. Waldmann H, Cobbold S. Regulating the immune response to transplants. A role for CD4 +regulatory cells? Immunity 2001 14 : 399 406.
35. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003 3 : 199 210.
36. Hall BM. Cells mediating allograft rejection. Transplantation 1991 51 : 1141 1151.
37. Steinmuller D. Which T cells mediate allograft rejection? Transplantation 1985 40 : 229 233.
38. Desai NM, Bassiri H, Kim J et al. Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocyte-deficient mice. Transplantation 1993 55 : 718 222.
39. Desai NM, Bassiri H, Odorico JS et al. Pancreatic islet allograft and xenograft survival in CD8 +T-lymphocyte-deficient recipients. Transplant Proc 1993 25 (1 Pt 2 961 962. (Pubitemid 23078855)
40. Osorio RW, Ascher NL, Jaenisch R, Freise CE, Roberts JP, Stock PG. Major histocompatibility complex class I deficiency prolongs islet allograft survival. Diabetes 1993 42 : 1520 1527.
41. Osorio RW, Ascher NL, Stock PG. Prolongation of in vivo mouse islet allograft survival by modulation of MHC class I antigen. Transplantation 1994 57 : 783 788.